Prescription drug · NDA
Brevibloc (Esmolol hydrochloride) NDC 10019-672
Esmolol hydrochloride 10 mg/mL · Injection · Intravenous · Baxter Healthcare Company
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10019-672-10 | 1001906721010019067210 | 10 BAG in 1 CARTON (10019-672-10) / 250 mL in 1 BAGMarketed from Jan 31, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brevibloc
- Generic name (nonproprietary)
- esmolol hydrochloride
- Active ingredients
- Esmolol hydrochloride — 10 mg/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- Baxter Healthcare CompanyNDC labeler code 10019
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019386
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 10019-672_49715de2-87bb-47f3-b039-66328a124bd8SPL ID 49715de2-87bb-47f3-b039-66328a124bd8SPL set ID 220a07b8-5c68-41a3-8705-fd91f14c50b4RxCUI 979432, 979434, 1736541, 1736543UNII V05260LC8D
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N410019067210followed by a unit qualifier and the quantityPackage 10019-0672-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
BREVIBLOC injection is a beta adrenergic blocker indicated for the short-term treatment of: • Control of ventricular rate in supraventricular tachycardia including atrial fibrillation and atrial flutter and control of heart rate in noncompensatory sinus tachycardia ( 1.1 ) • Control of perioperative tachycardia and hypertension ( 1.2 ) 1.1 Supraventricular Tachycardia or Noncompensatory Sinus Tachycardia BREVIBLOC (Esmolol Hydrochloride) injection is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is…
Excerpt only. Read the full label for complete information.
About NDC 10019-672
- What is NDC 10019-672?
- 10019-672 is the product NDC for Brevibloc (esmolol hydrochloride), Esmolol hydrochloride 10 mg/mL injection, listed with the FDA by Baxter Healthcare Company. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Brevibloc (Esmolol hydrochloride).
- What is the active ingredient?
- Esmolol hydrochloride.
- Who is the labeler?
- Baxter Healthcare Company, NDC labeler code 10019. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Brevibloc?
- 7 other product NDCs are listed under this name. See all Brevibloc NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Brevibloc products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Henry Schein, Inc | 0404-9825 | 00404-9825-10 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-055 | 10019-0055-61 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-075 | 10019-0075-87 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-115 | 10019-0115-01 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-666 | 10019-0666-10 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-668 | 10019-0668-10 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-670 | 10019-0670-10 |
Other NDCs under NDA 019386
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Henry Schein, Inc | 0404-9825 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-055 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-075 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-115 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-666 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-668 |
| Breviblocesmolol hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Company | 10019-670 |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Baxter Healthcare Corporation | 10019-120 |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1427 |
| Esmolol Hydrochloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | Medical Purchasing Solutions, LLC | 71872-7136 |